Genmab A/S (GNMSF) Assets Average (2021 - 2026)
Genmab A's (GNMSF) quarterly Assets Average came in at $12.6 billion in Q1 2026, up 94.22% YoY from $6.5 billion in Q1 2025, and up 26.92% on a QoQ basis from $9.9 billion in Q4 2025.
Genmab A/S (GNMSF) Assets Average (2021 - 2026) Analysis & Trends
Genmab A (GNMSF) has 5 years of Assets Average data on file, last reported at $12.6 billion in Q1 2026.
- Quarterly Assets Average rose 94.22% year-over-year to $12.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.6 billion (up 94.22% YoY) and the FY2025 annual result came in at $9.7 billion, changed N/A from the prior year.
- Assets Average climbed to $12.6 billion in Q1 2026, from $9.9 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $12.6 billion in Q1 2026 to a low of $2.6 billion in Q4 2023.
- A 4-year average of $6.8 billion and a median of $6.5 billion in 2025 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2025 — Assets Average soared 148.47% — and 2026, when it surged 94.22%.
- Tracing GNMSF's Assets Average over 4 years: stood at $2.6 billion in 2023, then changed by 0.0% to $2.6 billion in 2024, then surged by 280.24% to $9.9 billion in 2025, then climbed by 26.92% to $12.6 billion in 2026.
- The last three Assets Average figures came in at $12.6 billion (Q1 2026), $9.9 billion (Q4 2025), and $6.7 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.45 Bn |
| Mar 31, 2026 | 12.62 Bn |
| Dec 31, 2025 | 9.95 Bn |
| Sep 30, 2025 | 6.74 Bn |
| Jun 30, 2025 | 6.53 Bn |
| Mar 31, 2025 | 6.50 Bn |
| Mar 31, 2024 | 2.62 Bn |
| Dec 31, 2023 | 2.62 Bn |
| Mar 31, 2021 | 10,761,000.00 Bn |